West Pharma (WST) Tops Q1 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
West Announces First Quarter 2015 Results
April 30, 2015 7:01 AM EDTEXTON, PA -- (Marketwired) -- 04/30/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first quarter of 2015 and updated financial guidance for the full year 2015.
Highlights
Improved sales mix fuels wider gross margin and 21.6% growth in operating profit First-quarter diluted EPS rose 18.4% to $0.45 per share Reported sales declined 3.1% due to currency 6.5% growth in net sales at constant currency(1) Maintains 2015 constant currency sales growth estimate in the range of 6% to 8% Reported sales expected to be 1% to 2% lower Narrows... More